source
- Transposase-based cell line platform speeds development and raises protein yields for complex biologicsAdvanced cell line development tools are helping biopharma tackle the expression and stability challenges of increasingly complex molecules such as bispecifics and trispecifics. The article highli…
- Sleuth predicts surge in Western licensing of Chinese radioligand therapies by 2027Sleuth, a biopharma intelligence platform, says that while Chinese radiopharmaceutical assets have seen few licensing deals so far, the market is set to change. The firm notes that China now runs…